IPA
![Pharma industry seeks relief from price cap rule for cheap drugs](https://img.etimg.com/thumb/msid-111736665,width-100,height-75,resizemode-4/industry/healthcare/biotech/pharmaceuticals/pharma-industry-seeks-relief-from-price-cap-rule-for-cheap-drugs.jpg)
Pharma industry seeks relief from price cap rule for cheap drugs
India’s FoPE seeks a 10-year exemption for patented and low-cost drugs from price controls. Requests include DPCO and 12% GST adjustments due to 15-130% ingredient cost rises. Presenting to the DoP secretary, FoPE cites working capital issues prompting overseas research. Supported by IPA, Harish Jain stressed necessary revisions.
![Indians like to have a swig of premium beer](https://img.etimg.com/thumb/msid-111560182,width-100,height-75,resizemode-4/industry/cons-products/liquor/indians-like-to-have-a-swig-of-premium-beer.jpg)
Indians like to have a swig of premium beer
Premium beers significantly outpaced the overall beer market in FY24, with a 25-30% volume growth compared to the 8-10% growth of the beer category. Bira91's Taproom pubs in Ludhiana are finding success with flavored premium beers, challenging stereotypes in Punjab. Companies like United Breweries and AB InBev are capitalizing on the trend, with the Indian beer market projected to reach Rs 62,240 crore by 2028, driven by premiumization and changing consumer preferences.
![Risk-based audits of drug units to begin from July 1](https://img.etimg.com/thumb/msid-111322114,width-100,height-75,resizemode-4/industry/healthcare/biotech/pharmaceuticals/risk-based-audits-of-drug-units-to-begin-from-july-1.jpg)
Risk-based audits of drug units to begin from July 1
The revised Schedule M, which is considered more stringent than the World Health Organization's (WHO) good manufacturing practices (GMP) in certain areas, was notified on December 28, 2023. Companies with turnover of over ₹250 crore will have to comply with the upgraded version of Schedule M, starting July 1, and the remaining others, which are largely micro, small, and medium enterprises (MSMEs), have been given a year's time to comply. Inspections on those firms will begin from January 1, 2025.
![When a desi gets lost in McBritain's](https://img.etimg.com/thumb/msid-111025594,width-100,height-75,resizemode-4/opinion/et-commentary/when-a-desi-gets-lost-in-mcbritains.jpg)
When a desi gets lost in McBritain's
In the 15th century, Christopher Columbus landed in what he thought was India, but it was America. This case of mistaken identity caused the Italian navigator to call the local inhabitants 'Indios', Indians, an appellation that would be used for centuries to refer to indigenous Americans.
![Pill for China plus one](https://img.etimg.com/thumb/msid-110644755,width-100,height-75,resizemode-4/opinion/et-commentary/pill-for-china-plus-one.jpg)
Pill for China plus one
Indian pharma CEOs met senior officials in FDA and other key agencies to start a conversation. Even if a little late, given the looming presidential election, the proposal deserves attention. The basic idea is to capitalise on India's expertise and infra for manufacturing through financial incentives, tech sharing, collaborative research and tech transfers to expand production in both countries. Pursue onshoring in America and friendshoring in India to reduce dependence on China. And aggregate US, Indian and European demand for certain drugs, as IPA secretary general Sudarshan Jain told me.
![Microsoft hit with $242 million US verdict in Cortana patent lawsuit](https://img.etimg.com/thumb/msid-110026635,width-100,height-75,resizemode-4/tech/technology/microsoft-hit-with-242-million-us-verdict-in-cortana-patent-lawsuit.jpg)
Microsoft hit with $242 million US verdict in Cortana patent lawsuit
Microsoft ordered to pay $242 million to IPA for infringing IPA patent with Cortana. IPA under Wi-LAN. Lawsuit filed in 2018. Microsoft denies infringement. IPA also sued Google and Amazon.
- Go To Page 1
From overcapacity to TikTok, the issues covered during Janet Yellen's trip to China
Janet Yellen and her team wrapped up discussions in China, focusing on trade practices, money laundering, TikTok, and financial stability. While they addressed concerns like unfair trade practices and money laundering, issues like TikTok's future and financial stability cooperation remained unresolved.
Pharmaceutical bodies welcome uniform marketing code
"We welcome the UCPMP. It is a balanced order that ensures that there is a healthy and ethical engagement between the pharmaceutical industry and medical professionals," Indian Drug Manufacturers' Association (IDMA) national president Viranchi Shah said. "It also brings clarity in the domain and has been updated as per current industry practices. The IDMA has always been in favour of ethical marketing practices for its members."
Panel to review prices of drugs, medical devices
The government has constituted a panel to reform the pricing framework for drugs and medical devices. The committee will evaluate the availability and pricing of essential medicines, balance price and availability, and consider institutional reforms within the NPPA. It will also design a price moderation framework for medical devices and minimize imports.
Tech companies using content without consent: IPA prez Karine Pansa on AI-generated material
IPA president accuses big tech companies of using copyrighted content without permission for AI-generated materials. Urges publishers to raise concerns and discusses dealing with copyright infringement. Open letter to be penned. Lawsuits filed over AI training use. Embraces AI use, but emphasizes original creation by authors.
Widespread use of industrial-grade excipients unearthed in Indian pharmaceutical manufacturing
India's drug regulator, the Central Drugs Standard Control Organisation (CDSCO), has discovered the widespread use of industrial-grade excipients, unfit for human consumption, in the country's pharmaceutical manufacturing. Following international complaints, the CDSCO conducted investigations and inspections, revealing that unlicensed traders supplied industrial-grade gelatin, propylene glycol, and other excipients to pharmaceutical manufacturing units.
IBBI changes its norms to simplify registration of IPs
Through the latest changes, the IBBI has introduced a common application form for both enrolment and registration processes. It has also set a timeline of 60 days for the approval of the unified application (for enrolment) by the insolvency professional agency (IPA) and of 30 days for forwarding the application (for registration) to the regulator.
DCGI initiates review of pharma manufacturing standards to ensure drug quality and safety
India's drug regulator, the Drug Controller General of India (DCGI), plans to review pharmaceutical manufacturing standards in order to ensure the quality, safety, and efficacy of drugs. The DCGI will meet with pharma industry associations to discuss reviewing Good Manufacturing Practices (GMP) for pharma companies. The government aims to upgrade Schedule M, which lays down GMP, to international standards.
FM Sitharaman meets UK Trade Secretary; discusses investment, FTA
Finance Minister Nirmala Sitharaman on Saturday met UK Trade Secretary of State Kemi Badenoch and discussed bilateral investment and free trade agreement (FTA). " FM Smt. @nsitharaman and Secretary Ms. @KemiBadenoch briefly exchanged views and also reaffirmed the commitment by both sides for taking the ongoing negotiations on India-UK #FTA and India-UK #BIT to an early conclusion," the finance ministry tweeted.
Call on 'generics drugs only' clause after internal talks, says govt
The Indian Medical Association (IMA) has vehemently opposed the National Medical Commission Registered Medical Practitioner (Professional Conduct) Regulations, 2023, which mandate doctors to prescribe only generic drugs. The other contentious issue discussed during the meeting was medical conferences in five-star hotels with cocktail dinners.
Health Minister Mansukh Mandaviya to discuss issues related to newly notified regulations by NMC today
The Union health minister Mansukh Mandaviya is likely to hold a meeting today to discuss issues related to newly notified regulations by the National Medical Comissioner (NMC). The meeting will be held with the Indian Medical Association (IMA) officials, drug lobby group-Indian Pharmaceutical Alliance (IPA) and officials from the ministry and NMC.
Cargo traffic at major ports declines 1.96 pc to 64.63 MT in June: IPA
Cargo traffic at the country's major ports declined 1.96 per cent year-on-year to 64.63 million tonnes (MT) in June, with seven ports posting a negative growth while five such facilities saw a surge in traffic, an official release said on Tuesday. There are 12 major ports spanning across India under the administrative control of the central government.
All medicines to be sold under supervision of pharmacist, mandates DCGI
Newly-appointed DCGI Rajeev Singh Raghuvanshi has asked the state drug controllers to ensure that pharmacists should be physically present in the medical stores and that medicines must be sold under their direct supervision in retail pharmacies.
Cargo traffic at major ports rises 12 pc in February: IPA
India has 12 major ports -- Deendayal (Kandla), Mumbai, Mormugao, New Mangalore, Cochin, Chennai, Ennore (Kamarajar), Tuticorin (V O Chidambaranar), Visakhapatnam, Paradip and Kolkata (including Haldia) and Jawaharlal Nehru Port.
Budget wishlist: Pharma, healthcare industry seek simplified regulations, research-based incentives
Outlining the wishlist for the sector in the upcoming Union Budget, Indian Pharmaceutical Alliance (IPA) Secretary General Sudarshan Jain said the domestic pharma industry is currently around USD 50 billion in size and aspires to grow to around USD 130 billion by 2030 and USD 450 billion by 2047.
Pharma association gives clean chit to Dolo-maker
The IPA has submitted a report to the Department of Pharmaceuticals (DoP) and National Pharmaceutical Pricing Authority (NPPA) stating that the company was "following the processes as per the Uniform Code of Pharmaceutical Marketing Practices (UCPMP) guidelines" and they did not find any wrong doing.
Drugmakers' body IPA says it's examining the controversy around Dolo medicine
Micro Labs has rejected the allegations, terming them as "baseless". Sudarshan Jain, secretary general of IPA, told ET its member companies including Micro Labs follow strict code of conduct. The industry is governed by Uniform Code of Pharmaceutical Marketing Practices (UCPMP), he said.
Exempt cheap drugs from price control, say Indian Pharmaceutical Alliance
Mehta batted for a market friendly pricing structure which will help in accessibility of medicines to the patients and increase investment in research and overall export thrust in global market.
South Korea strike disrupts shipments of key cleaning agent for chipmaking
The truckers' union, which is protesting against soaring fuel prices and demanding guarantees of minimum pay, vowed to continue the strike after four rounds of talks with the government have failed to find a resolution.
Government may 'rationalise' drug trade margins in a bid to reduce costs
The meeting was attended by representatives from the Indian Drug Manufacturers Association (IDMA) and Indian Pharmaceutical Alliance (IPA), The Organisation of Pharmaceutical Producers of India (OPPI), and All India Drug Action Network (AIDAN), among others. The All India Organisation of Chemists and Druggists (AIOCD) has suggested a 10% trade margin for wholesale dealers on PTR (price to retailer) and 20% for retailers on MRP.
Exclude cheap drugs from price control: IPA
Sudarshan Jain, secretary general of IPA, in an interview to ET said "We are not against price controls; what we are saying is that the government should exclude low-priced scheduled products from price control or allow at least 10% annual hike as it is done for non-scheduled formulations," Jain said.
Cargo traffic at major ports rises by 11.43 pc in August
India has 12 major ports under the control of the central government -- Deendayal (erstwhile Kandla), Mumbai, JNPT, Mormugao, New Mangalore, Cochin, Chennai, Kamarajar (earlier Ennore), VO Chidambarnar, Visakhapatnam, Paradip and Kolkata (including Haldia).
Realisation there in pharma industry to become self reliant in API production: IPA
"Reliance on China for APIs is there...We had the technology of making all kinds of APIs but over a period of time we lost that advantage. But now with production linked incentive (PLI) scheme which covers APIs and coming up of manufacturing parks we are on the right path," (IPA) Secretary General Sudarshan Jain said during an event.
Urgent action required to revive the pharma ancillary industry: IPA
For the revival of the ancillary industry, several short-term and long-term efforts are required to be made by all stakeholders, a report on the theme of 'Reviving the Pharma Ancillary industry - A Roadmap with Resilience to Excellence' by IPA and Accenture has said.
Load More